Stent Overexpansion and Myocardial No-Reflow

Notably, no-reflow was increased in the overexpansion group when compared with the nonoverexpansion group (32% vs. 11%, respectively, p = 0.031), and heart failure was seen more often (28% vs. 14%, respectively, p = 0.036), although there was less target lesion revascularization during follow-up in...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2009-12, Vol.54 (24), p.2340-2341
Main Authors: Kapoor, John R., MD, PhD, Kapoor, Roger, MD, MBA
Format: Article
Language:English
Subjects:
Angioplasty, Balloon, Coronary
Cardiology
Cardiovascular
Heart attacks
Humans
Internal Medicine
Myocardial Infarction - surgery
Myocardial Infarction - therapy
Prosthesis Design
Stents
Stents - adverse effects
Treatment Failure
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Notably, no-reflow was increased in the overexpansion group when compared with the nonoverexpansion group (32% vs. 11%, respectively, p = 0.031), and heart failure was seen more often (28% vs. 14%, respectively, p = 0.036), although there was less target lesion revascularization during follow-up in the overexpansion group (3). [...]during coronary stenting, the risks of stent overexpansion should be weighed against the benefits to limit the potential for harm.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2009.09.028